Forte T - Search Results

1

Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion.

Parolini C, Chiesa G, Zhu Y, Forte T, Caligari S, Gianazza E, Sacco MG, Sirtori CR, Rubin EM. Parolini C, et al. Among authors: forte t. J Biol Chem. 2003 Feb 14;278(7):4740-6. doi: 10.1074/jbc.M207335200. Epub 2002 Dec 5. J Biol Chem. 2003. PMID: 12471038 Free article.

2

Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano).

Chiesa G, Stoltzfus LJ, Michelagnoli S, Bielicki JK, Santi M, Forte TM, Sirtori CR, Franceschini G, Rubin EM. Chiesa G, et al. Among authors: forte tm. Atherosclerosis. 1998 Jan;136(1):139-46. doi: 10.1016/s0021-9150(97)00195-0. Atherosclerosis. 1998. PMID: 9544740

3

Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model.

Parolini C, Chiesa G, Gong E, Caligari S, Cortese MM, Koga T, Forte TM, Rubin EM. Parolini C, et al. Among authors: forte tm. Atherosclerosis. 2005 Dec;183(2):222-9. doi: 10.1016/j.atherosclerosis.2005.03.008. Epub 2005 Apr 21. Atherosclerosis. 2005. PMID: 16285990

4

Apolipoprotein AI expression and high density lipoprotein distribution in transgenic mice during development.

Golder-Novoselsky E, Forte TM, Nichols AV, Rubin EM. Golder-Novoselsky E, et al. Among authors: forte tm. J Biol Chem. 1992 Oct 15;267(29):20787-90. J Biol Chem. 1992. PMID: 1383210 Free article.

5

Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.

Ng DS, Francone OL, Forte TM, Zhang J, Haghpassand M, Rubin EM. Ng DS, et al. Among authors: forte tm. J Biol Chem. 1997 Jun 20;272(25):15777-81. doi: 10.1074/jbc.272.25.15777. J Biol Chem. 1997. PMID: 9188474 Free article.

6

High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.

Bielicki JK, Forte TM, McCall MR, Stoltzfus LJ, Chiesa G, Sirtori CR, Franceschini G, Rubin EM. Bielicki JK, et al. Among authors: forte tm. J Lipid Res. 1997 Nov;38(11):2314-21. J Lipid Res. 1997. PMID: 9392429 Free article.

7

Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.

Lindholm EM, Bielicki JK, Curtiss LK, Rubin EM, Forte TM. Lindholm EM, et al. Among authors: forte tm. Biochemistry. 1998 Apr 7;37(14):4863-8. doi: 10.1021/bi972888i. Biochemistry. 1998. PMID: 9538003

8

Human apo A-I in transgenic mice is more efficient in activating lecithin:cholesterol acyltransferase than mouse apo A-I.

Golder-Novoselsky E, Nichols AV, Rubin EM, Forte TM. Golder-Novoselsky E, et al. Among authors: forte tm. Biochim Biophys Acta. 1995 Jan 20;1254(2):217-20. doi: 10.1016/0005-2760(94)00230-v. Biochim Biophys Acta. 1995. PMID: 7827127

9

Evidence that apolipoprotein A-IMilano has reduced capacity, compared with wild-type apolipoprotein A-I, to recruit membrane cholesterol.

Bielicki JK, McCall MR, Stoltzfus LJ, Ravandi A, Kuksis A, Rubin EM, Forte TM. Bielicki JK, et al. Among authors: forte tm. Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1637-43. doi: 10.1161/01.atv.17.9.1637. Arterioscler Thromb Vasc Biol. 1997. PMID: 9327756

10

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins.

Oda MN, Bielicki JK, Ho TT, Berger T, Rubin EM, Forte TM. Oda MN, et al. Among authors: forte tm. Biochem Biophys Res Commun. 2002 Jan 25;290(3):921-7. doi: 10.1006/bbrc.2001.6295. Biochem Biophys Res Commun. 2002. PMID: 11798161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters